Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Metabolic Profile May ID Early Ovarian Cancer
...
Already a member? Log in here
12-Hour Urine Collection OK For Preeclampsia Diagnosis
...
Already a member? Log in here
Patients Prefer Test Results Through Password-Protected Portals
...
Already a member? Log in here
Special Focus: The Rise of Liquid Biopsy Testing
From - Diagnostic Testing & Emerging Technologies
Early in the year DTET spoke to experts that predicted 2015 would be the year that liquid biopsy technology penetrates the clinical oncology market. These predictions did not disappoint. A near continuous stream of publications, conference presentations, and…
23andMe’s Return Signals Expected Growth in DTC Market
...
Already a member? Log in here
Molecular Tests Should Not be Standalone Diagnostic for C. Diff
...
Already a member? Log in here
Lipid Panels May Be Useful in Diagnosing Migraines
...
Already a member? Log in here
Urinalysis Overuse in ER Has Repercussions
...
Already a member? Log in here